01 1Grace
01 1ORPHENADRINE CITRATE USP
01 1U.S.A
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2015-12-16
Pay. Date : 2013-07-05
DMF Number : 5722
Submission : 1985-02-22
Status : Active
Type : II
20
W R Grace And Co -conn, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is ORPHENADRINE CITRATE USP, with a corresponding US DMF Number 5722.
Remarkably, this DMF maintains an Active status since its submission on February 22, 1985, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 16, 2015, and payment made on July 05, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
